Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Connett

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
The European Respiratory Journal|February 7, 2009
Leptin receptor polymorphisms and lung function decline in COPDN N Hansel, L Gao, N M Rafaels, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2012
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosisT W V Daniels, G B Rogers, F A Stressmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 1, 2010
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF studyA J Matas, R Leduc, D Rush, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failureR B Mannon, A J Matas, J Grande, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2019
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosaOdel Soren, Ardeshir Rineh, Diogo G Silva, et al.
The Journal of Pediatrics|October 10, 2018
Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic ReviewMohan Pammi, Charitharth Vivek Lal, Brandie D Wagner, et al.
Thorax|September 24, 2021
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trialsRuth H Keogh, Rebecca Cosgriff, Eleni-Rosalina Andrinopoulou, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2016
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae BiofilmsSamuel A Collins, Michael J Kelso, Ardeshir Rineh, et al.
FEMS Microbiology Letters|September 1, 2017
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosisWynne D Smith, Emmanuelle Bardin, Loren Cameron, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The European Respiratory Journal|February 7, 2009
Leptin receptor polymorphisms and lung function decline in COPDN N Hansel, L Gao, N M Rafaels, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2012
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosisT W V Daniels, G B Rogers, F A Stressmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 1, 2010
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF studyA J Matas, R Leduc, D Rush, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failureR B Mannon, A J Matas, J Grande, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2019
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosaOdel Soren, Ardeshir Rineh, Diogo G Silva, et al.
The Journal of Pediatrics|October 10, 2018
Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic ReviewMohan Pammi, Charitharth Vivek Lal, Brandie D Wagner, et al.
Thorax|September 24, 2021
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trialsRuth H Keogh, Rebecca Cosgriff, Eleni-Rosalina Andrinopoulou, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2016
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae BiofilmsSamuel A Collins, Michael J Kelso, Ardeshir Rineh, et al.
FEMS Microbiology Letters|September 1, 2017
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosisWynne D Smith, Emmanuelle Bardin, Loren Cameron, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 12